NEW YORK STATE COMMON RETIREMENT FUND - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,468,000
-76.2%
42,600
-88.5%
0.00%
-75.0%
Q2 2020$6,180,000
+17.7%
369,843
+1.6%
0.01%0.0%
Q1 2020$5,251,000
-59.6%
364,143
-6.2%
0.01%
-46.7%
Q4 2019$12,988,000
+127.2%
388,038
+42.2%
0.02%
+114.3%
Q3 2019$5,716,000
+476.8%
272,972
+473.5%
0.01%
+600.0%
Q2 2019$991,000
+4.3%
47,600
+12.0%
0.00%0.0%
Q1 2019$950,000
-6.6%
42,5000.0%0.00%0.0%
Q4 2018$1,017,000
-22.7%
42,500
-11.8%
0.00%
-50.0%
Q3 2018$1,315,000
+1.5%
48,2000.0%0.00%0.0%
Q2 2018$1,296,000
+4.1%
48,200
+23.3%
0.00%0.0%
Q1 2018$1,245,000
-63.8%
39,100
-57.0%
0.00%
-50.0%
Q4 2017$3,442,000
+269.3%
91,023
+142.1%
0.00%
+300.0%
Q3 2017$932,000
+20.6%
37,6000.0%0.00%0.0%
Q2 2017$773,000
+32.1%
37,600
+39.8%
0.00%0.0%
Q1 2017$585,000
+6.4%
26,901
+0.0%
0.00%0.0%
Q4 2016$550,000
+36.1%
26,9000.0%0.00%0.0%
Q3 2016$404,000
+38.8%
26,9000.0%0.00%
Q2 2016$291,000
+100.7%
26,900
+151.4%
0.00%
Q1 2016$145,000
-26.4%
10,7000.0%0.00%
Q4 2015$197,00010,7000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,100,146$117,248,00040.96%
TLP GROUP LLC 1,050,000$39,711,00027.53%
Aisling Capital LLC 2,240,000$84,717,00016.74%
Foresite Capital Management III, LLC 764,824$28,926,0008.12%
AlpInvest Partners B.V. 51,498$1,948,0006.95%
Vivo Capital, LLC 643,626$24,342,0005.21%
GREAT POINT PARTNERS LLC 573,550$21,692,0003.70%
Eventide Asset Management 1,226,000$46,367,0002.42%
Palo Alto Investors LP 1,146,419$43,358,0001.87%
HAMILTON LANE ADVISORS LLC 78,846$2,982,0001.54%
View complete list of AIMMUNE THERAPEUTICS INC shareholders